HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hector Chinoy Selected Research

Travel-Related Illness

1/2022The challenges of antirheumatic therapy and travel-associated infections.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hector Chinoy Research Topics

Disease

33Myositis (Idiopathic Inflammatory Myopathies)
11/2022 - 11/2004
12Inclusion Body Myositis
02/2022 - 11/2009
10Dermatomyositis (Dermatopolymyositis)
01/2021 - 11/2004
8Muscular Diseases (Myopathy)
12/2020 - 10/2013
7Necrosis
11/2018 - 11/2009
6Neoplasms (Cancer)
01/2021 - 01/2006
6Polymyositis
01/2020 - 11/2004
6Psoriatic Arthritis
01/2020 - 08/2013
6Rheumatoid Arthritis
01/2020 - 02/2015
5Rheumatic Diseases (Rheumatism)
11/2019 - 05/2015
4Psoriasis (Pustulosis Palmaris et Plantaris)
07/2022 - 02/2014
4COVID-19
01/2022 - 01/2021
4Interstitial Lung Diseases (Interstitial Lung Disease)
01/2021 - 01/2006
3Systemic Scleroderma (Systemic Sclerosis)
01/2020 - 05/2015
3Muscle Weakness
01/2016 - 10/2013
2Connective Tissue Diseases (Connective Tissue Disease)
11/2022 - 01/2020
2Inflammation (Inflammations)
01/2022 - 11/2015
2Rhabdomyolysis
12/2019 - 01/2019
2Vasculitis (Vasculitides)
11/2018 - 01/2017
2Melanoma (Melanoma, Malignant)
02/2018 - 11/2013
2Autoimmune Diseases (Autoimmune Disease)
04/2016 - 01/2016
2Disease Susceptibility (Diathesis)
01/2006 - 11/2004
1Neurodegenerative Diseases (Neurodegenerative Disease)
02/2022
1Simian Acquired Immunodeficiency Syndrome
01/2022
1Travel-Related Illness
01/2022
1Weight Gain
12/2021
1Sarcopenia
01/2021
1Muscular Dystrophies (Muscular Dystrophy)
01/2021
1Exanthema (Rash)
01/2021
1Atrophy
01/2021
1Diarrhea
01/2021
1Osteoporosis
12/2020
1Calcinosis
11/2020
1Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2020
1Fatigue
01/2020
1Sjogren's Syndrome (Sjogren Syndrome)
01/2020
1Pain (Aches)
01/2020
1Agammaglobulinemia (Hypogammaglobulinemia)
05/2019
1Infections
01/2019
1Hemorrhage
01/2019
1Myocardial Infarction
01/2019
1Spasm (Spasms)
01/2019
1Drug-Related Side Effects and Adverse Reactions
01/2019
1Adenocarcinoma of Lung
01/2019
1Musculoskeletal Diseases (Musculoskeletal Disease)
11/2018

Drug/Important Bio-Agent (IBA)

17AutoantibodiesIBA
11/2022 - 10/2007
15AntibodiesIBA
11/2022 - 01/2006
9Pharmaceutical PreparationsIBA
01/2020 - 02/2014
5Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
12/2020 - 10/2013
4Biomarkers (Surrogate Marker)IBA
07/2022 - 11/2013
4Proteins (Proteins, Gene)FDA Link
02/2022 - 01/2016
4HLA-DRB1 Chains (HLA DRB1)IBA
01/2017 - 11/2004
3EpitopesIBA
01/2021 - 04/2016
3AntigensIBA
01/2021 - 07/2007
3Ligases (Synthetase)IBA
12/2020 - 01/2020
3Oxidoreductases (Dehydrogenase)IBA
10/2020 - 10/2013
3Biological ProductsIBA
06/2019 - 02/2014
2InterferonsIBA
01/2022 - 11/2020
2VaccinesIBA
01/2022 - 01/2022
2GlucocorticoidsIBA
12/2021 - 01/2021
2Creatine Kinase (Creatine Phosphokinase)IBA
01/2021 - 01/2020
2AutoantigensIBA
01/2021 - 01/2020
2bimagrumabIBA
01/2021 - 01/2019
2MicroRNAs (MicroRNA)IBA
01/2020 - 11/2015
2Tumor Necrosis Factor InhibitorsIBA
01/2020 - 01/2016
2Messenger RNA (mRNA)IBA
01/2020 - 11/2004
2transcriptional intermediary factor 1IBA
11/2019 - 01/2019
2Amino AcidsFDA Link
11/2019 - 01/2017
2Certolizumab PegolFDA Link
06/2019 - 01/2017
2Immunoglobulins (Immunoglobulin)IBA
05/2019 - 01/2019
2Amyloid (Amyloid Fibrils)IBA
01/2019 - 07/2015
2Monoclonal AntibodiesIBA
01/2019 - 02/2018
2TroponinIBA
01/2018 - 05/2015
2ametantrone (HAQ)IBA
01/2018 - 09/2010
2Peptides (Polypeptides)IBA
01/2017 - 04/2016
2HLA Antigens (Human Leukocyte Antigens)IBA
11/2016 - 10/2013
2Adalimumab (Humira)FDA Link
11/2016 - 05/2015
2Rituximab (Mabthera)FDA Link
01/2016 - 03/2013
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
05/2015 - 11/2004
2EnzymesIBA
05/2015 - 10/2013
1SolutionsIBA
01/2022
1L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
01/2021
1Biocompatible Materials (Biomaterials)IBA
01/2021
1SteroidsIBA
12/2020
1Pharmacological BiomarkersIBA
01/2020
1Eukaryotic Initiation Factor-3IBA
01/2020
1indolepropanol phosphate (IPP)IBA
01/2020
1RNA (Ribonucleic Acid)IBA
01/2020
1CreatineIBA
12/2019
1Immunoglobulin G (IgG)IBA
05/2019
1Interferon Type IIBA
01/2019
1Hypnotics and Sedatives (Sedatives)IBA
01/2019
1Sirolimus (Rapamycin)FDA Link
01/2019
1florbetapirIBA
01/2019
1Interferon-alpha (Interferon Alfa)IBA
01/2019
1Antidepressive Agents (Antidepressants)IBA
01/2019
1NivolumabIBA
02/2018

Therapy/Procedure

9Therapeutics
01/2022 - 10/2013
1Anterior Cruciate Ligament Reconstruction
01/2021
1Cell Transplantation
01/2021